More likely a 20 to life schedule for many of dabneys fellow liars thieves and con artists...:-)
December 14, 2011
DENVER--(BUSINESS WIRE)-- Cannabis Science, Inc. (OTCBB:CBIS.ob), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce it has entered final negotiations to bring Cannabis Science Brand of Pharmaceutical products into California.
Following the release of our cannabis extract based formulation in Colorado, and international anecdotal cases reports from patients with Cancer, Cannabis Science is finalizing agreements to expand our business into California.
This new strategic partnership would allow Cannabis Science to better satisfy the demand for its formulations by making them available to more than 1.4 million cancer patients in California. This strategic alliance also brings to the table significant resources for Cannabis Science in California including laboratories for quality assurance and testing, an educational platform to distribute information about the science of cannabis (everything on should know from the seed to sale) Additionally, as part of the deal we will acquire organically produced strains for our scientific medicinal formulations. Furthermore, if California goes fully legal in 2014, it should bring down production costs and savings could be passed along to the patients.
Dr. Melamede stated “ For too long patients have requested our formulations, as a result we have gathered anecdotal reports thru personal testimonials that have demonstrated to us the need for our products in California. We look forward to bringing these products thru the California regulatory system in the near future. Similarly, as the laws allow, we intend to bring our products to other medical marijuana states through additional strategic mergers, acquisitions, and partnerships.
News 
Market Data 
Discover 
